KRAS and non-small cell lung carcinoma: A phase III trial (KRYSTAL-12) evaluating adagrasib monotherapy versus docetaxel in pretreated patients with KRAS c.34G > T (p.G12C)-mutated NSCLC is ongoing (ClinicalTrials.gov NCT04685135).